Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.

Kumar V, Yi Lo PH, Sawai H, Kato N, Takahashi A, Deng Z, Urabe Y, Mbarek H, Tokunaga K, Tanaka Y, Sugiyama M, Mizokami M, Muroyama R, Tateishi R, Omata M, Koike K, Tanikawa C, Kamatani N, Kubo M, Nakamura Y, Matsuda K.

PLoS One. 2012;7(9):e44743.

2.

Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.

Lo PH, Urabe Y, Kumar V, Tanikawa C, Koike K, Kato N, Miki D, Chayama K, Kubo M, Nakamura Y, Matsuda K.

PLoS One. 2013 Apr 11;8(4):e61279. doi: 10.1371/journal.pone.0061279.

3.

Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.

Al-Qahtani AA, Al-Anazi M, Abdo AA, Sanai FM, Al-Hamoudi W, Alswat KA, Al-Ashgar HI, Khalaf N, Viswan N, Al-Ahdal MN.

Exp Mol Pathol. 2013 Dec;95(3):255-8. doi: 10.1016/j.yexmp.2013.08.005.

PMID:
23994040
4.

Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants.

Tong HV, Toan NL, Song LH, Bock CT, Kremsner PG, Velavan TP.

J Viral Hepat. 2013 Oct;20(10):687-98. doi: 10.1111/jvh.12089.

PMID:
24010643
5.

Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.

Lange CM, Bibert S, Dufour JF, Cellerai C, Cerny A, Heim MH, Kaiser L, Malinverni R, Müllhaupt B, Negro F, Semela D, Moradpour D, Kutalik Z, Bochud PY; Swiss Hepatitis C Cohort Study Group..

J Hepatol. 2013 Sep;59(3):504-9. doi: 10.1016/j.jhep.2013.04.032.

PMID:
23665287
6.

Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma.

Li JJ, Pan K, Gu MF, Chen MS, Zhao JJ, Wang H, Liang XT, Sun JC, Xia JC.

Chin J Cancer. 2013 Mar;32(3):141-8. doi: 10.5732/cjc.012.10025.

7.

Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.

Kumar V, Kato N, Urabe Y, Takahashi A, Muroyama R, Hosono N, Otsuka M, Tateishi R, Omata M, Nakagawa H, Koike K, Kamatani N, Kubo M, Nakamura Y, Matsuda K.

Nat Genet. 2011 May;43(5):455-8. doi: 10.1038/ng.809.

PMID:
21499248
8.

Association of major histocompatibility complex class I chain-related gene A microsatellite polymorphism and hepatocellular carcinoma in South China Han population.

Jiang X, Zou Y, Huo Z, Yu P.

Tissue Antigens. 2011 Aug;78(2):143-7. doi: 10.1111/j.1399-0039.2011.01693.x.

PMID:
21644931
9.

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.

Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF.

PLoS One. 2011;6(12):e28486. doi: 10.1371/journal.pone.0028486.

10.

Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma.

Kohga K, Takehara T, Tatsumi T, Ohkawa K, Miyagi T, Hiramatsu N, Kanto T, Kasugai T, Katayama K, Kato M, Hayashi N.

Cancer Sci. 2008 Aug;99(8):1643-9. doi: 10.1111/j.1349-7006.2008.00859.x.

11.

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM.

Infect Genet Evol. 2011 Dec;11(8):2083-8. doi: 10.1016/j.meegid.2011.09.025.

PMID:
22019522
12.
13.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
14.

MICA SNPs and the NKG2D system in virus-induced HCC.

Goto K, Kato N.

J Gastroenterol. 2015 Mar;50(3):261-72. doi: 10.1007/s00535-014-1000-9. Review.

PMID:
25270965
15.

Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.

Chen K, Shi W, Xin Z, Wang H, Zhu X, Wu X, Li Z, Li H, Liu Y.

PLoS One. 2013 Oct 28;8(10):e77315. doi: 10.1371/journal.pone.0077315.

16.

The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis.

Takeuchi Y, Ikeda F, Moritou Y, Hagihara H, Yasunaka T, Kuwaki K, Miyake Y, Ohnishi H, Nakamura S, Shiraha H, Takaki A, Iwasaki Y, Nouso K, Yamamoto K.

J Gastroenterol. 2013 Mar;48(3):405-12. doi: 10.1007/s00535-012-0647-3.

PMID:
22869157
17.

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.

Ohkubo K, Kato Y, Ichikawa T, Kajiya Y, Takeda Y, Higashi S, Hamasaki K, Nakao K, Nakata K, Eguchi K.

Cancer. 2002 May 15;94(10):2663-8.

18.

High levels of soluble Major Histocompatibility Complex class I related chain A (MICA) are associated with biliary cast syndrome after liver transplantation.

Zou Y, Yang X, Jiang X, Wang H, Hao Q, Liu Y, Yu P.

Transpl Immunol. 2009 Sep;21(4):210-4. doi: 10.1016/j.trim.2009.06.003.

PMID:
19539762
19.

Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.

Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, Hayashi N.

J Hepatol. 2005 Dec;43(6):1013-20.

PMID:
16168521
20.

Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.

Li H, Liu F, Zhu H, Zhou X, Lu J, Chang H, Hu J.

Med Sci Monit. 2016 Feb 19;22:549-53.

Items per page

Supplemental Content

Support Center